PTPRC and sarcoidosis: In vivo analysis of α-MSH-treated granulomas in sarcoidosis mice model revealed a numerical decrease in all measured leukocytes and cytokines, with a statistically significant reduction in CD45+CD68 and CD45+CD3+CD8 in granuloma + α-MSH group relative to the granuloma group.